Recent Updates
Recently added Catalysts
ENOV Positive Sentiment Score: 70/100

Enovis to Participate in Investor Conferences in June

Key Takeaway: Enovis Corporation has announced its participation in several key investor conferences in June 2023. The Chief Financial Officer, Ben Berry, will represent the company at the Jefferies Healthcare Conference and the JMP Securities Mid-Year MedTech Forum. Additionally, the Chief Executive Officer, Matt Trerotola, will join Berry at the Goldman Sachs 44th Annual Global Healthcare Conference. This engagement highlights Enovis's commitment to innovation in the medical technology sector.

Market Sentiment Analysis

POSITIVE FACTORS

  • Management team actively engaging with investors.
  • Participation at reputable investor conferences.
  • Company showcases dedication to innovation and growth.

Full Press Release Details

Wilmington, DE, June 02, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences in June:
Jefferies Healthcare Conference: On Wednesday, June 7th, Ben Berry, Chief Financial Officer, will be meeting with investors at the conference which is scheduled to take place in New York, NY.
Goldman Sachs 44th Annual Global Healthcare Conference: On Tuesday, June 13th, Matt Trerotola, Chief Executive Officer, and Ben Berry, Chief Financial Officer, will be meeting with investors at the conference, which is scheduled to take place in Dana Point, CA.
JMP Securities Mid-Year MedTech Forum: On Thursday, June 22nd, Ben Berry, Chief Financial Officer, will be meeting with investors at the event which is scheduled to take place in Boston, MA.
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Vice President, Investor Relations
Source: Enovis Corporation

Frequently Asked Questions

What is Enovis Corporation known for?

Enovis Corporation specializes in innovation-driven medical technology and solutions.

When is the Jefferies Healthcare Conference?

The Jefferies Healthcare Conference is on June 7th in New York, NY.

Who represents Enovis at the Goldman Sachs conference?

Matt Trerotola and Ben Berry will represent Enovis at the Goldman Sachs conference.

What is the focus of Enovis's product development?

Enovis focuses on clinically differentiated solutions for better patient outcomes.

Where can I find more information about Enovis?

More information about Enovis can be found at www.enovis.com.

Last updated: Jun 2, 2023